Vancomycin
Back to searchMolecule Structure
Scientific Name
Vancomycin
Description of the Drug
Vancomycin is a glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00512
http://www.drugbank.ca/drugs/DB00512
Brand Name(s)
Not Available
Company Owner(s)
Watson Laboratories Inc, Orient Pharma Co Ltd, Xellia Pharmaceuticals Aps, Emcure Pharmaceuticals Ltd, Akorn Operating Co Llc, Aspiro Pharma Ltd, Fresenius Kabi Usa Llc, Steriscience Pte Ltd, Hainan Poly Pharm Co Ltd, Hospira Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Peptidoglycan | MACROMOLECULE | INHIBITOR | CHEMBL3041361 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3177 | ||
PharmGKB | PA451850 | ||
Human Metabolome Database | HMDB0014653 | ||
DrugBank | DB00512 | ||
PubChem: Thomson Pharma | 14842128 | 14842127 | |
PubChem | 14969 | ||
NMRShiftDB | 60058693 | ||
LINCS | LSM-45214 | ||
Nikkaji | J34.275K | ||
BindingDB | 50335519 | ||
EPA CompTox Dashboard | DTXSID0042664 | ||
DrugCentral | 2807 | ||
Metabolights | MTBLC28001 | ||
Guide to Pharmacology | 10932 | ||
rxnorm | VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN | VANCOCIN |
ChEBI | 28001 |